Tadashi Makino

This inventor holds 25 USPTO granted patents, primarily in Pharmaceutical Formulations. Top assignees: Takeda Chemical Industries, Inc., Senju Pharmaceutical Co., Ltd.. Active years: 1977-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tadashi Makino. Retrieved from https://idiyas.com/inventor/tadashi-makino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 88.0

Average Co-Inventor Count = 3.0

ph-index = 16

Forward Citations = 1,211(Granted Patents)

Location History:

Takatsuki, JA (1977)
Ibaraki, JP (1986 - 2001)
Osaka, JP (1991 - 2004)

Company Filing History:

23 out of 1,858

Takeda Chemical Industries, Inc.

patents

2 out of 229

Senju Pharmaceutical Co., Ltd.

patents

Years Active: 1977-2004

Loading Chart...

Areas of Expertise:

Stabilized Composition

Pharmaceutical Preparation

Fast Dissolving Tablet

Granule Production

Buccal Disintegrability

Oral Administration

Antacid Compositions

Spherical Granules

Antibacterial Composition

L-Ascorbic Acid Tablets

Solid Pharmaceutical Preparation

Divisible Tablet

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6749864 - Stabilized pharmaceutical composition (2004-06-15),

2. 6521256 - Stabilized pharmaceutical composition (2003-02-18),

3. 6380234 - Stabilized pharmaceutical composition and its production (2002-04-30),

4. 6296875 - Method for producing a granule (2001-10-02),

5. 6248357 - Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility (2001-06-19),

6. 6123962 - Process for producing stabilized pharmaceutical composition (2000-09-26),

7. 6017560 - Process for producing stabilized pharmaceutical composition (2000-01-25),

8. 5958453 - Solid pharmaceutical preparation with improved buccal disintegrability (1999-09-28),

9. 5879708 - Stabilized pharmaceutical composition (1999-03-09),

10. 5739165 - Stabilized solid pharmaceutical preparation and method of producing the (1998-04-14),

11. 5720974 - Fast dissolving tablet and its production (1998-02-24),

12. 5651997 - Antacid compositions (1997-07-29),

13. 5639478 - Method to stabilize a pharmaceutical composition and its production (1997-06-17),

14. 5534534 - Pharmaceutical compositions for oral use and method of preparing them (1996-07-09),

15. 5520929 - Divisible tablet (1996-05-28),

Title: Tadashi Makino: Innovator in Pharmaceutical Chemistry

Introduction

Tadashi Makino, located in Osaka, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a remarkable portfolio of 25 patents, he has become a key figure in advancing medication formulation and stabilization techniques.

Latest Patents

Among his latest innovations is a 'Stabilized Pharmaceutical Composition'. This formulation aims to enhance the stability and efficacy of pharmaceutical products, ensuring better therapeutic outcomes for patients. The emphasis on stabilization reflects the growing importance of longevity and effectiveness in drug delivery systems.

Career Highlights

Throughout his career, Tadashi Makino has collaborated with prominent companies in the pharmaceutical industry. He worked with Takeda Chemical Industries, Inc., a leading global innovator in pharmaceuticals, where his contributions to pharmaceutical development were instrumental. Additionally, his tenure at Senju Pharmaceutical Co., Ltd. allowed him to further hone his skills and expertise in drug composition and formulation.

Collaborations

Tadashi Makino's work has been enhanced through collaborations with esteemed colleagues such as Shin-Ichiro Hirai and Tetsuro Tabata. These partnerships have fostered a fruitful exchange of ideas and innovations, promoting advancements in pharmaceutical research and development.

Conclusion

With a solid foundation in research and development, Tadashi Makino continues to be a driving force in the innovation of stabilized pharmaceutical compositions. His dedication and expertise in the field significantly contribute to the improvement of drug formulations, ultimately benefiting patient care and pharmaceutical advancements.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]